Ownership

June Almenoff - Director at Avalo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director
Stock Symbol: AVTX on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

June Almenoff - trading volume in the past year for Avalo Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+1K	100%	$12.75	+$12.7K
Sells
Net	+1K	100%		+$12.7K

Holdings reported by June Almenoff for Avalo Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Restricted Stock Units	6.33K	$53.6K	$8.46	Mar 28, 2025	Direct	Common Stock
Common Stock	3.17K	$26.8K	$8.46	Mar 28, 2025	Direct
Common Stock	1K	$8.46K	$8.46	Mar 28, 2025	By Meadowlark Management, LLC
Stock Option (Right to Buy)	24.6K			Aug 13, 2024	Direct	Common Stock

Transactions reported by June Almenoff for Avalo Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.